Trauma-Focused Therapy Proven Safe and Effective for PTSD in Psychosis Patients
- Trauma-focused therapy is safe and effective for patients with both psychosis and post-traumatic stress disorder (PTSD), according to research from King's College London.
- The research, reported June 21, 2026, by Neuroscience News, suggests that targeted psychological interventions can be integrated into the treatment of patients with complex mental health profiles without...
- Researchers at King's College London utilized trauma-focused therapy to address the specific needs of patients suffering from comorbid psychosis and PTSD.
Trauma-focused therapy is safe and effective for patients with both psychosis and post-traumatic stress disorder (PTSD), according to research from King’s College London. The findings indicate that these interventions can reverse PTSD symptoms, contradicting long-held clinical beliefs that patients experiencing psychosis are too fragile for trauma-focused care.
The research, reported June 21, 2026, by Neuroscience News, suggests that targeted psychological interventions can be integrated into the treatment of patients with complex mental health profiles without increasing the risk of psychotic relapse.
How does trauma therapy work for patients with psychosis?
Researchers at King’s College London utilized trauma-focused therapy to address the specific needs of patients suffering from comorbid psychosis and PTSD. This approach involves structured psychological interventions designed to help patients process traumatic memories and reduce the distress associated with them.

The treatment focuses on the neurobiology of trauma and its impact on memory. By utilizing Cognitive Behavioral Therapy (CBT) adapted for PTSD, clinicians help patients identify and modify the maladaptive beliefs and triggers that sustain PTSD symptoms.
According to the findings, this method does not destabilize the patient. Instead, it provides a framework for recovery that addresses the underlying trauma which often co-occurs with or contributes to psychotic symptoms.
Why was this treatment previously avoided?
For decades, a prevailing clinical consensus suggested that individuals with psychosis were too unstable to handle the emotional intensity of trauma-focused therapy. Clinicians feared that revisiting traumatic events would trigger severe psychotic episodes or lead to further psychological decompensation.
This perception created a treatment gap where patients with dual diagnoses were often denied the standard of care available to those with PTSD alone. Treatment typically focused on the management of psychotic symptoms through medication and general support, while the trauma remained unaddressed.
The King’s College London study explicitly challenges the notion that these patients are too fragile
for such work. The data shows that when delivered correctly, trauma-focused therapy is a viable and safe option for this population.
What are the neurobiological implications of these findings?
The research emphasizes the intersection of psychology and neurobiology. Trauma impacts the brain’s memory systems and stress response mechanisms, which can overlap with the neurobiological markers of psychosis.

By reversing PTSD symptoms, the therapy helps stabilize the patient’s overall mental state. This suggests that treating the trauma may reduce the overall psychological burden, potentially making the management of psychotic symptoms more effective.
The study highlights that memory processing is a key component of this recovery. When patients can successfully integrate traumatic memories, the frequency and intensity of PTSD-related intrusions decrease, which may in turn reduce the stress levels that often exacerbate psychosis.
How does this change current clinical practice?
The results from King’s College London provide a basis for updating clinical guidelines. Rather than viewing psychosis as a contraindication for trauma therapy, the evidence suggests that trauma-focused care should be considered a standard component of treatment for patients with comorbid PTSD.
This shift moves the treatment model from purely symptomatic management to a comprehensive recovery approach. It allows clinicians to address the root causes of distress rather than focusing solely on the suppression of psychotic symptoms.
The study indicates that the safety of these interventions depends on the use of evidence-based protocols, such as adapted CBT, which ensure the patient remains supported throughout the process of trauma processing.
Future applications of this research may involve expanding these protocols to a wider range of psychotic disorders and exploring how different types of trauma—such as childhood abuse or combat experience—respond to these specific therapeutic interventions.
